Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Appropriate Antibiotic Use for Acute Otitis Media
Your Article Summary
Dexamethasone inner ear perfusion for subclinical endolymphatic hydrops
ENT Journal, 04/03/09
Silverstein H et al. - Cochlear hyrops has been described as a variant or early manifestation of Meniere disease in which the patient experiences fluctuating hearing loss with tinnitus and aural fullness or pressure. This condition is believed to be caused by an elevated level of endolymphatic pressure, which is likely due to poor absorption from the endolymphatic sac or excess secretion of endolymph, and results in distention of Reissner's membrane. The clinical presentation of patients with cochlear, or endolymphatic, hydrops is variable, although patients presenting with fluctuating hearing seem to outnumber those presenting with true Méniere disease.
Related Articles
Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial : The Lancet Oncology
The Lancet Oncology - Online First, 10/23/09
Relevance Score: 94%
Survival effect of venous thromboembolism in patients with multiple myeloma treated with lenalidomide and high-dose dexamethasone
Journal of Clinical Oncology, 11/13/09
Relevance Score: 91%
The Effect of Topical Combined Ciprofloxacin 0.3% and Dexamethasone 0.1% on Children with Otitis Media with Effusion(OME) Undergoing Myringotomy
Middle East Journal of Family Medicine, 10/21/09
Relevance Score: 88%
Phase 2 trial results with the novel neurokinin-1 receptor antagonist casopitant in combination with ondansetron and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in cancer patients receiving moderately emetogenic chemotherapy
Cancer, 10/20/09
Relevance Score: 88%
Dexamethasone decreases oxycodone consumption following osteotomy of the first metatarsal bone: a randomized controlled trial in day surgery
Acta Anaesthesiologica Scandinavica, 10/30/09
Relevance Score: 87%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Clinical use of botulinum toxins in oral and maxillofacial surgery
International Journal of Oral and Maxillofacial Surgery, 03/09/10
The Effects of topical viscous lignocaine 2% versus per-rectal diclofenac in early post-tonsillectomy pain in children
International Journal of Pediatric Otorhinolaryngology , 03/09/10
Degrees of dysplasia and the use of cidofovir in patients with recurrent respiratory papillomatosis
The Laryngoscope, 03/08/10
Today in Otology/Neurotology...keeping you current
Receive free subspecialty "5-minute updates" via email
Creutzfeldt-Jakob disease affecting the maxillofacial region
British Journal of Oral & Maxillofacial Surgery, 03/10/10
Glucocorticoids reduce nitric oxide concentration in middle ear effusion from lipopolysaccharide induced otitis media
International Journal of Pediatric Otorhinolaryngology , 03/09/10
Middle ear aneurysm treated with an innovative, vessel-preserving, aneurysm-occluding stent
The Laryngoscope, 03/09/10
Article Search
Sponsor


See Latest Articles


